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Resumo 
 
 
Toxoplasma gondii é considerado um parasita zoonótico, causando 
toxoplasmose congênita, uma doença prevalente em todo o mundo com 
implicações graves para o feto. Os mecanismos que desempenham um papel, 
induzindo patologia durante a infeção por este parasita não são claros, mas 
são potencialmente associados com alterações dos processos homeostáticos 
imunológicos normais, incluindo a ativação de macrófagos. Os macrófagos 
apresentam uma variedade de estadios de ativação descritos como ativação 
inata (ligação TLR), clássica/M1 (ligação TLR com IFN) ou alternativa/M2 
(ligação IL4Ralpha). Assim, enquanto os macrófagos M1 controlam a 
replicação dos parasitas pela indução de sintetase do óxido nítrico induzível 
(NOS2), os macrófagos M2 controlam a replicação dos parasitas induzindo a 
arginase-1 (Arg-1) e depletando a arginina.  
O nosso estudo incidiu sobre os efeitos da infeção por T. gondii, na expressão 
de Arg-1 e de NOS2 na interface feto-materna (FMI) e a nível sistémico 
(células de exsudado peritoneal e células do baço) utilizando murganhos como 
modelo de estudo.  
A infeção de animais gestantes Balb/c e C57BL/6 (B6) com uma estirpe de T. 
gondii tipo II permitiu o acompanhamento da gravidez. A análise morfométrica 
da decídua e da placenta foi realizada utilizando seções de unidades feto-
placentárias coradas com hematoxilina-eosina. A determinação da carga 
parasitária foi realizada por PCR quantitativo em tempo real utilizando sondas 
Taqman (q-PCR). A expressão de Arg-1 e NOS2 foi avaliada por qRT-PCR, 
Imuno-histoquímica e Western-Blotting.  
Observou-se uma diminuição significativa na área da placenta e da decídua 
em B6 infetados em comparação com os animais controlo, mas não nos 
animais Balb/c. A análise imunohistoquímica indicou um aumento da 
expressão de Arg-1 e uma diminuição da expressão de NOS2 na decídua de 
animais infetados em comparação com os animais controlo em ambas as 
estirpes. Os resultados obtidos sugerem que a infeção interfere com o 
processo de placentação atrasando a decidualização, podendo existir uma 
relação com as alterações da expressão de Arg-1 e NOS2 nos B6, mas não 
nos animais Balb/c. O trabalho desenvolvido visa não só a compreensão do 
papel da ativação de macrófagos na infeção congénita pelo T. gondii, mas 
poderá fornecer informações essenciais sobre o papel dos macrófagos durante 
uma gravidez saudável e uma gravidez com infeção. 
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Abstract 
 
Toxoplasma gondii is considered to be the world’s most successful zoonotic 
parasite, causing congenital toxoplasmosis, a prevalent disease worldwide with 
serious implications for the fetus. The mechanisms playing a role in the 
induction of pathology during infection are not clear, but are potentially 
associated with disruption of normal homeostatic immunological pathways 
including macrophage activation. Macrophages have a variety of activation 
states, being able to adapt their functions to environmental changes of 
cytokines, described as innate (TLR ligation), classical/M1 (TLR ligation with 
IFN) or alternative/M2 (IL4Ralpha ligation) activation states. Thus, while 
classical macrophage activation can control replication through induction of 
inducible nitric oxide synthase (NOS2), alternative activation can control 
parasite replication through induction of arginase 1 (Arg-1) and depletion of 
arginine.  
Our study was focused on the effects of T. gondii infection on Arg-1 and NOS2 
expression at the fetomaternal interface (FMI) and systemic level (peritoneal 
exudate cells and spleen cells) using the mice model. 
Infection of pregnant BALB/c and C57Bl/6 (B6) mice with a type II strain of T. 
gondii allowed the follow-up of pregnancy. Morphometric analysis of decidua 
and placenta was performed using haematoxylin-eosin sections of the 
fetoplacental units. The parasite loads’ evaluation was done by quantitative 
Real Time-PCR (q-PCR) using Taqman probes. Arg-1 and NOS2 expression 
were evaluated by qRT-PCR, immunohistochemistry and Western Blotting.  
It was observed a significant decrease in placental and decidual areas in 
infected B6 compared to control but not in Balb/c mice. Immunohistochemical 
analysis indicated an increased expression of Arg-1 and a decreased 
expression of NOS2 in the decidua from infected compared to control animals 
from both strains of mice. This indicates that infection interferes with the 
process of placentation delaying decidualization and this might be correlated 
with altered expression of Arg-1 and NOS2 in B6 but not in Balb/c mice. This 
work aims not only understanding the role of macrophage activation in 
congenital infection by T. gondii, but also should provide valuable information 
regarding the role of macrophages during healthy pregnancy and infection 
complicated pregnancy. 
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1. Toxoplasma gondii 
 
Toxoplasma gondii (T. gondii) is a protozoan parasite of the Apicomplexa 
phylum (1) and Coccidiasina subclass (2), with cats as definitive host and other 
warm-blooded animals as intermediate hosts (3). It was first discovered by Nicolle 
and Manceaux during a leishmaniosis research project at the Pasteur Institute in 
Tunis (4). In the beginning, they have confused the parasite as a piroplasm, later 
designated as Leishmania, but soon they realized that had discovered a new 
organism (5). Based on the morphology (toxo=arc, plasma=life) and the host 
(Ctenodactylus gundi) it was named Toxoplasma gondii (Fig. 1) (6). Thereafter, T. 
gondii-like organisms were detected, but the first viable T. gondii was isolated by 
Sabin and Olitsky (7). 
T. gondii has a worldwide distribution, but there is only one specie (8). 
Different methods were established to identify genetic differences between T. 
gondii isolates from humans and animals (9,10). In 2005, Khan et al., performed 
the mapping of T. gondii genes, which definitely was determinant in understanding 
the disease pathology mechanisms, and for the search of better antigens for 
diagnosis and vaccination (11). 
T. gondii infection is common, affecting about one third of the world 
population (12), while developing toxoplasmosis only occurs in rare situations such 
as in immunocompromised hosts and in pregnant women (13). 
The primary infection in pregnant women can cause congenital 
toxoplasmosis, that might lead to abortion, fetal growth restriction, mild 
chorioretinitis, mental retardation microcephaly, hydrocephalus, seizures (14) or 
ocular disease, being this late sequel, undoubtedly the most common of congenital 
toxoplasmosis (15). 
 
 
Figure 1.  Tachyzoites analysed by scanning electron microscopy. Scale 2 µm. (16) 
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2. Structure and Life Cycle 
 
There are three infection stages of T. gondii: tachyzoites (Figure 2A), 
bradyzoites (Figure 2B-C) and sporozoites (Figure 2G) (15). 
 
 
 
 
Figure 2.  Stages of T. gondii. (A) Tachyzoites in impression smear of lung. Note: crescent-
shaped individual tachyzoites (arrows) and dividing tachyzoites (arrowheads) compared with size 
of host red blood cells and leukocytes. (B) Tissue cists with bradyzoites in a section of muscle. 
Note: tissue cyst wall (arrow) and bradyzoites (arrowheads). (C) Brain tissue cists with sporozoites. 
Note: tissue cyst wall (arrow) and sporozoites (arrowheads). (D) Schizont (arrow) with several 
merozoites (arrowheads), impression smear of infected cat intestine. (E) A male gamete with two 
flagella (arrows). (F) Unsporulated oocyst in fecal float of cat feces. Note: double layered wall 
(arrow). (G) Sporulated oocyst. Note: oocyst wall (large arrow), two sporocysts (arrowheads). Each 
sporocyst has four sporozoites (small arrow). Scale bar in (A-D) = 20 mm, in (E-G) = 10 mm. (15) 
 
 
After the ingestion of tissue cysts by cats, the cyst wall is dissolved in the 
small intestine and the bradyzoites are released and penetrate the epithelial cells, 
thereby initiating the development of asexual and sexual cycles of T. gondii (Fig. 
3) (17). After penetrating into the epithelial cells, the bradyzoites can multiply as 
tachyzoites and, within a few hours, may disseminate to extraintestinal tissues 
forming cysts in the heart and brain persisting several months and possible for the 
lifespan of the cat (17). 
As the asexual cycle progresses, the sexual cycle also occurs, as T. gondii 
multiplies as schizonts (Fig. 2D) in intestinal epithelial cells of cats. The merozoites 
released from schizonts form the male gamete, with two flagella (Fig. 3E), and the 
female gamete after fertilization form the oocyst. After maturation, the oocysts are 
released into the intestinal lumen (15). Upon ingesting any of the infection stages 
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of T. gondii, cats release oocysts that take 1-5 days to sporulate and become 
infectious (Fig. 2G) (15,18,19). Oocysts are the resistant stage and are only 
formed in felids (definitive hosts, where the sexual cycle occurs) (19).  
Oocysts, containing sporozoites, spread in the environment and 
contaminate water, soil, fruits and vegetables, which can be then ingested by 
humans and other animals (intermediate hosts, where occurs asexual phase). 
Humans can also be contaminated by ingestion of cysts, containing bradyzoites, 
found in raw or undercooked meat from previously infected animals (Fig.3) (20). T. 
gondii transmission can also occur through blood transfusions and organ 
transplants (21).  
Sporozoites and bradizoites invade the gastro-intestinal tube, undergoing 
multiplication in the form of tachyzoites that disrupt the infected cells and invade 
new cells (20). With the onset of immune response, there is a reduction in parasite 
load. The development of tissue cysts (with bradyzoites) remain latent throughout 
host lifespan in tissues such as lymph nodes, muscle, brain, retina, myocardium, 
lung and liver (14). However in immunosuppressed individuals, bradyzoites can 
restart their division and spread again as tachyzoites (14). 
 
 
 
Figure 3.  Life cycle of Toxoplasma gondii (22). 
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3. Transmission 
 
In 1939, Wolf et al, described congenital T. gondii infection in a human child 
and later, it was also found in several animal species (23). However, congenital 
transmission occurs very rarely, which does not explain the worldwide spread of 
the infection. In 1954, Weinman and Chandler proposed that transmission could 
occur through the ingestion of undercooked meat (24), which was later comproved 
through the demonstration of  T. gondii cysts resistance to proteolytic enzymes 
(25).  
While congenital transmission and ingestion of undercooked meat 
explained some of the T. gondii transmission, it did not explain infection of 
vegetarian and herbivore hosts. In 1965, Hutchison found T. gondii infectivity 
associated with cat feces (26–29). Finally, T. gondii life cycle was completely 
described, with the discovery of the sexual phase of the parasite in the cat gut. It 
was found that T. gondii oocysts derived from gametogony and schizogony 
(30,31). These oocysts released with cat feces could contaminate food and water 
being subsequently ingested by animals and humans (12), originating the fecal-
oral route of infection, explaining vegetarians and herbivores infection. 
 
 
4. Infection in humans 
 
Most human infections are asymptomatic, but sometimes the parasite can 
produce devastating disease. Congenital infection occurs, only when a woman 
becomes infected during pregnancy.  
Infection may occur in any organ, but the most common observed clinical 
form of toxoplasmosis in humans are enlarged lymph nodes, associated with 
fever, fatigue, headache, among other symptoms (32). In immunosuppressed 
patients, encephalitis is the most important clinical form of toxoplasmosis, causing 
serious damage, such as hemiparesis, convulsions and coma (33). In acquired 
immune deficiency syndrome (AIDS) patients, brain infection is the most frequently 
clinical form reported. The predominant lesion in the brain is necrosis, especially of 
the thalamus (34). 
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4.1. Congenital Toxoplasmosis 
 
Congenital Toxoplasmosis is caused by vertical transmission of T.gondii 
tachyzoites from a primary acute infected pregnant woman to the fetus. In 
immunocompetent hosts, infection usually results in life-long immunity, so if a 
primary infection is acquired at least 4-6 months before conception, protective 
immunity usually prevents vertical transmission on subsequent exposures, except 
in immunocompromised woman whose infection can be reactivated (e.g AIDS) 
(35,36). 
Besides causing complications to the fetus, as abortion and neonatal 
mortality, this disease can also reduce the quality of life in children, who survive 
prenatal infection, causing mild chorioretinitis, mental retardation microcephaly, 
hydrocephalus, seizures and ocular disease (35). 
Worldwide, 3-8 infants per 1000 live births are infected in the uterus, and 
there are multiple factors associated with this infection, including transmission 
route, cultural behavior, eating habits, hygienic standards and climatic conditions 
(37,38). 
The risk of congenital infection increases with gestational age (Table 1). 
However, when infection occurs at later gestation stages, less serious will be the 
consequences for the fetus (36). 
 
 
            Table 1.  Risk of Human T. gondii congenital infection and development of  
            clinical signs in offspring, according to maternal gestational age. Adapted  
            from (39). 
 
Gestational weeks when 
maternal seroconversion 
occurs 
Risk of congenital 
Infection % 
Development of clinical 
signs in the infected 
offspring % 
13 (≈ 3 Mo) 6  61 
26 (≈ 7 Mo) 40 25 
36 (≈ 9 Mo) 72 9 
            
           NOTE: this analysis was performed with 603 women, whose T. gondii infection was 
           documented to have occurred during gestation. Mo = Months. 
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5. Infection in animals 
 
In addition to humans, T. gondii, is also able to cause infection and severe 
disease in domestic animals (38). In sheep and goats, it causes embryonic death, 
abortion, stillbirth and neonatal death, causing great losses for producers. 
Outbreaks of toxoplasmosis in pigs and also sporadically in rabbits, mink and 
other domestic animals have also been reported (40). 
According to serologic surveys, T. gondii infections have also been 
demonstrated in carnivores (chinchillas, mink, ferrets, foxes, raccoons and 
raccoon dogs), wild pigs, wild felids (feral cats, lynx, bobcats, jaguars and ocelots), 
sea mammals (sea lions, seals, dolphins and whales), wild ungulates (gazelles, 
deers, bisons and reindeers), small mammals (rats, mice, rabbits, porcupines, 
guinea pigs and squirrels), monkeys, marsupials and birds, with more serious 
consequences for some than for others (15). 
 
 
6. Epidemiology 
 
T. gondii infections occur all around the world, although infection rates differ 
significantly  depending on the geographic localization (Fig. 4) (41). A survey 
performed in the 1990s following childbearing age women, indicated that 
seroprevalences ranged between 37-58% in Central European countries, 51-72% 
in several Latin-American countries and 54-77% in West African countries. Lower 
seroprevalences have been reported in Southeast Asia, China, Korea (4-39%) and 
in areas with a cold climate, such as the Scandinavian countries (11-28%) (35). 
Toxoplasmosis is also a risk for laboratory workers since, 47 laboratory-
acquired cases have been reported,  being 81% symptomatic cases (42). In the 
United States, data from the National Health and Nutrition Examination Survey 
(NHANES), between 1999 and 2004, found 9% of US-born persons, with ages 
between 12-49 years, compared to a previously survey performed, between 1988 
and 1994 indicating 14,1% of seroprevalence (43). These surveys and others, 
indicated a trend of decreasing seroprevalence in the United States and many 
European countries (41). 
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Figure 4.  Global status of T. gondii seroprevalence. Adapted from (41). 
 
There are about 225 thousand cases of T. gondii infection per year 
worldwide, resulting in about 5000 hospitalizations and 750 deaths, making T. 
gondii the third most common cause of fatal diseases foodborne (14). 
The reasons for the dissemblance in the prevalence of toxoplasmosis in 
different countries have been attributed to different causes. For instance, the high 
prevalence of infection in Europe, has been related to a preference for raw or 
undercooked meat, while the high prevalence in Central America and in other 
developing countries has been related to low socio-economic levels and the 
frequency of stray cats in a friendly climate for oocysts survival. Besides, the 
infection is most common in warm climates and at lower altitudes than in cooler, 
drier climates and mountainous regions (44). 
There are three major genotypes of T. gondii responsible for the 
Toxoplasmosis throughout the world: type I, II, and III. These T. gondii strains 
have different effects depending on the host, due to their genotype variations (45). 
 Type I: virulent in mice and humans, detected in AIDS patients. 
 Type II: non-virulent in mice, virulent in humans (found in Europe and 
North America), detected in AIDS patients.  
 Type III: non-virulent in mice, most frequent strain from animals, 
detected in a lower degree in humans. 
Current serotyping techniques only allowed differential identification of 
strain I and III from strain II (46). 
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Because the parasite is a threat to the fetus when contracted during 
pregnancy, most of the global epidemiological information concerning T. gondii 
comes from seropositivity tests in woman of childbearing age. Seropositivity tests 
guarantee only the exposure to the parasite, but not chronical infection (47). 
 
 
7. Diagnosis 
 
The diagnosis of toxoplasmosis can be made by three different assays: 
 Immunological assays: T. gondii infection induces the production of 
antibodies against specific T. gondii antigens (48). These antibodies can be 
detected in the blood using several immunoassays as VIDAS avidity assay (49) 
and Dot-ELISA (50). Acute toxoplasmosis can be differentiated from chronic 
toxoplasmosis using flow-cytometry or vitek immune diagnostic assay system 
(VIDAS) avidity assays to quantify the presence of different types of antibodies 
(49,51). Acute patients are positive for immunoglobulin (Ig) M antibodies, but 
have a low IgG avidity index, whereas, chronic patients can be positive or 
negative for IgM antibodies but will have a high IgG avidity index (Fig. 5). 
Differentiation between acute and chronic infections is important, since acute 
infection of pregnant women can be transmitted to the fetus and cause 
complications in fetal development (52). However, chronic infections may also 
be reactivated during pregnancy and infect the fetus in immunocompromised 
individuals (53).  
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Figure 5.  Guidelines for serological testing and management of toxoplasmosis during 
pregnancy on the basis of initial results obtained from T. gondii IgG and IgM antibody tests. 
CT= Congenital Toxoplasmosis (36). 
 
 Deoxyribonucleic acid (DNA) assays: toxoplasmosis can be detected 
in various tissues or body fluids by polymerase chain reaction (PCR) using 
probes for T. gondii specific DNA sequences (49,54). PCR is useful to 
diagnose fetal toxoplasmosis because it can detect T. gondii in amniotic fluid 
(52). Recently, a new and faster method called loop-mediated isothermal 
amplification (LAMP) has been developed. It can detect T. gondii DNA in 
mouse urine and, in the future, it will be useful for routine diagnosis and 
therapeutic evaluation in humans (55). 
 Imaging: toxoplasmosis is a common treatable cause of brain lesions 
in immunocompromised patients. These lesions can be detected on an 
magnetic resonance imaging (MRI), computed tomography (CT), or positron 
emission tomography (PET) scans (54,56). When lesions are detected, 
treatment is immediately initiated and if symptoms improve, then toxoplasmosis 
is inferred as being the cause of the lesions. 
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8. Prevention and Control 
 
Prevention of T. gondii infection might be done in two stages: 
 Primary prevention: the efforts of prevention have primarily been 
directed towards health education, avoiding personal exposure to the parasite. 
So, hands, cutting boards, sink tops, knives and other materials should be 
washed with soap and water after handling meat (57). T. gondii parasite 
present in meat can be killed by exposure to extreme cold (-13ºC) (58) or heat 
(67ºC) temperatures (59). Thus, meat of any animal should be frozen or well-
cooked before consumption. Pet cats should be fed only with dry, canned or 
cooked food and the litter box should be emptied and washed every day. The 
vegetables should be well-washed before consumption (60). 
The development of a vaccine can prevent human disease, by immunization of 
humans as well as animals. Much work has been done focused on a surface T. 
gondii antigen (SAG1), attempting to induce host protective immune response, 
but, until now, there is no effective vaccine preventing toxoplasmosis in 
humans (61). 
 Secondary prevention: in many countries routine toxoplasmosis 
screening programs for pregnant women have been established (62). Woman 
screening should begin before the conception with follow-up of monthly tests 
during pregnancy (63). A recent study in the United States screened neonates 
for T. gondii specific IgM and the confirmed cases of congenital toxoplasmosis 
where treated. Seven years after treatment, patients revealed no symptoms or 
at least no disease progression. Based on this, authors suggested that 
toxoplasmosis neonatal screening programs should be implemented in order to 
prevent disease (64). 
In conclusion, it is crucial the population education in order to minimize risks 
of infection. Also screening programs implementation, of childbearing age or 
pregnant women, as well as, of newborn babies should be highly effective for early 
treatment and prevention of sequelae. 
 
 
 
   
 
Determination of Arginase 1 and Nitric Oxide Synthase expression during pregnancy and Toxoplasma 
gondii infection 
 
 
 
12 
9. Treatment 
 
In immunocompetent individuals, chronic toxoplasmosis is usually untreated 
because tissue cysts are asymptomatic and resistant to drugs (65). 
There are available a number of drug therapies for acute toxoplasmosis 
treatment. In humans, the recommended treatment for acute toxoplasmosis is the 
administration of a combination of pyrimethamine and sulfadiazine (given with 
folinic acid to prevent a reduction in platelet count) (66). To prevent congenital 
transmission in pregnant women, spiramycin has been used, because is non-toxic 
and does not cross the placenta (67,68). However, a study in rhesus monkeys 
showed that spiramycin may prevent transmission of infection to the fetus, but, 
most probably, cannot interrupt brain infection, which is the most severe outcome 
of congenital toxoplasmosis in humans (69). Sulphonamides, trimethoprim, 
pyrimethamine and clindamycin, either alone or in combination, as well as 
ponazuril are being studied as possible treatments for cats (70).  
Treatments in immunosuppressed individuals with chronic disease are 
being tested (71), consisting of drugs that target specifically the isoprenoid 
pathway, the dihydrofolate reductase, the T. gondii histone deacetylase, or type II 
fatty acid biosynthesis pathway showing some promise as possible future 
treatments (54,71). 
 
 
10.   Immune Cell Populations at the fetomaternal interface (FMI) 
 
A successful pregnancy requires that the maternal immune system adapts 
properly to avoid rejection of semi-allogeneic fetus, without compromising the 
ability to protect the mother and the fetus from infections. 
There is an intimate association between mother and the fetus during 
pregnancy, however the maternal tissue never comes into direct contact with the 
developing fetus. This indirect connection is formed at FMI constituted by decidual 
cells (maternal component) and trophoblast cells (fetal component) (72). 
The human decidua is a dynamic immunological tissue within the uterus 
composed by a large population of maternal immune cells, able to actively change 
its constitution along the pregnancy process (73). After decidua differentiation, an 
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extensive uterine vasculature remodelling occurs with the enlargement of maternal 
blood vessels duo to trophoblast invasion (74,75). The human placenta is a 
multifunctional organ responsible for secretion and synthesis of several important 
hormones, cytokines and growth factors, crucial for pregnancy maintenance and 
fetal protection, being highly active during the first trimester of pregnancy and it 
slowly decreases by the end of gestation (76). 
Placental tissue contains paternal antigens that under normal conditions 
would trigger a maternal immune response, however during normal pregnancy this 
immune response does not occur (72). The fetomaternal tolerance is ensured by a 
tight and complex regulation of T cell functions, particularly T-helper (Th) cells, 
ensuring fetal protection and survival. Among several mechanisms, it is described 
a limited immunosuppressive state of the maternal immune response, allowing 
tolerance to fetal alloantigens expressed by the placenta, thus, preventing fetal 
rejection (77,78). Interestingly, this tolerance to fetal alloantigens occurs in the 
presence of a large number of maternal leukocytes. Therefore, intense 
reproductive research has its focus on leukocyte populations present in the 
endometrium and decidua from infertile women and women with obstetric 
complications (79). 
The major populations of leukocytes present in the decidua in the 1st 
trimester are: natural killer cells (NK) (70%), macrophages (20%), regulatory T 
lymphocytes (Treg) (10-20%) and dendritic cells (DCs) (rare) (80). Macrophages 
together with NK cells, contribute to tissue remodeling process, and together with 
Treg cells play a central role in keeping a homeostatic environment between 
maternal and fetal components (Fig. 6) (81). 
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Figure 6.  Schematic representation of FMI. MΦ: macrophages; NK: natural killer cells; DC: 
dendritic cells; T: lymphocytes; Treg: regulatory T lymphocytes; EVT: trophoblasts; CTB: 
cytotrophoblasts (81). 
 
 
10.1. Trophoblasts 
 
Trophoblast cells protect the fetus against infection and are considered as a 
component of the innate immune system (82). 
Initially trophoblast cells from the trophectoderm of blastocyst that 
proliferate, differentiate and invade the decidua giving rise to the placenta (83). 
These cells, express paternal antigens and exhibit unique features, not expressing 
classical major histocompatibility complex (MHC) class I receptors, avoiding 
recognition by maternal T cells and thus preventing maternal immune rejection 
(84). However, they do express non-classical receptors, escaping from NK cell-
mediated toxicity that may occur during pregnancy (83,85). 
The trophoblasts main functions include fetus protection, nevertheless, in 
some situations, placental trophoblast cells may also initiate signals that are able 
to promote fetal rejection (82). These cells are able to recognize pathogens that 
induce toll-like receptor (TLR)-mediated trophoblast inflammatory or apoptotic 
responses, impacting in the production of chemokines and cytokines. The 
production of these factors influence the differentiation, migration and activation of 
macrophages, NK, Treg, DCs at the decidua, which may shift from a protective to 
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an aggressive phenotype promoting fetal rejection (73,82). Trophoblasts are then 
required for parasite transmission since they are strategically located between the 
maternal and fetal blood circulation systems, therefore being efficiently infected for 
instance with T. gondii (83).  
 
 
10.2. NK and Decidual NK cells 
 
Decidual NK (dNK) cells are the major leukocyte cell population at the 
decidua and uterine mucosa, during implantation and early pregnancy (79,86). At 
the first trimester of pregnancy, NK cells constitute about 70% of total human 
decidual leukocytes (80), decreasing in number during the second trimester (87). 
Due to its close contact, dNK cells interact with the invading fetal-derived 
trophoblast cells, helping them during migration and contributing to the remodeling 
of decidual spiral arteries into high conductance blood vessels, thereby allowing a 
sufficient blood flow supply at the FMI, determinant in a healthy gestation 
(74,81,85). Rather than work as cytotoxic effector cells, the major function of NK 
cells during pregnancy comprises the secretion of a variety of angiogenic factors, 
including vascular endothelial growth factor (VEGF), angiopoietin-2, nutritional 
cytokines and growth factors, such as tumor necrosis factor-α (TNF-α), TNF-β, 
interleukin (IL)-10, IL-13, granulocyte-macrophage colony-stimulating factor (GM-
CSF) and interferon gamma (IFN-γ) (79,87). The secretion of IFN-γ by dNK cells, 
an essential Th1-type cytokine controlling trophoblasts invasion at the FMI during 
pregnancy, induces trophoblasts apoptosis via a caspase mediated-pathway (88).  
NK cells contribute to early resistance to T. gondii (89,90) by recognizing 
and killing infected cells. In fact, they have shown to be the major source of IFN-γ 
early in infection (89). After T. gondii infection, the traffic of NK cells is first 
increased into the lymph node and then into the site of infection, producing IFN-γ 
and therefore inducing classically activate macrophages with increased MHC class 
II molecules expression (91). These cells possess a number of chemokine 
receptors such as C-C chemokine receptor (CCR)-5 facilitating this process (91). 
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10.3. Decidual Macrophages 
 
Decidual macrophages constitute the second most abundant immune cell 
population in decidua, being about 20% of the decidual leucocyte population 
(81,92).  
Macrophages are responsible for decidual homeostasis, placental 
development and tolerance to the semi-allogeneic trophoblast. They also form a 
major line of defense against invading pathogens in the decidua, protecting, 
therefore, the fetus from infection (93). Decidual macrophages are able to 
decrease the cytolytic activity of dNK cells against the invading trophoblasts, 
contributing to the maintenance and support of uterine tissue homeostasis and 
remodelling (75,79,81). Decidual macrophages recognize, phagocyte, control and 
eliminate pathogens, promoting the normal fetal development and acceptance, 
preventing tissue damage and fetal rejection (75,79,81,84). 
 
 
10.3.1. Macrophage Activation 
 
Macrophages have long been recognized as phagocytic cells, responsible 
for eliminating pathogens that invade any living vertebrate or invertebrate (94). 
They play not only a critical role in innate immunity, but also help in the adaptive 
immunity, by recruiting other immune cells such as lymphocytes, that are the 
major antigen-specific cells responsible for macrophage activation (95). Beyond 
increasing inflammation and stimulating the immune system, macrophages also 
play an important anti-inflammatory role through the release of cytokines (including 
chemokines, interferons, ILs, lymphokines and TNF) (96). 
TLRs are a proteins class expressed in sentinel cells (such as 
macrophages and DCs) that play a key role in the innate immune system. They 
recognize structurally conserved molecules derived from pathogens, such as 
lipopolysaccharide (LPS) and activate immune cell responses. TLRs and IL-1 
receptors form a receptor superfamily having in common the toll-IL-1 receptor 
(TIR) domain (97). 
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A number of different activation states for macrophages are considered: 
innately activated through LPS stimulation (or other TLR ligands), classically 
activated (M1) through a combination of LPS and IFN-γ, and alternatively activated 
(M2) through IL4/IL13 signaling. M1-type macrophages are critical for host 
defense against intracellular pathogens and interfere in antitumor immunity and 
autoimmune inflammation. M2 macrophages are protective against helminth 
parasites and are important regulators of the wound healing response, tissue 
homeostasis and adiposity (98).  
In the presence of pathogens, M1 and M2 macrophage responses induce a 
Th1/Th2 responses, although both M1 and M2 macrophages functions, occur in all 
animals whether they have or not T cells (99). 
During the course of an inflammatory response, phenotypic switching of 
macrophages from an M1 to an M2 profile has been observed, underscoring the 
dual role of macrophages in initiating and subsequently resolving inflammation. 
Whether this switch occurs by local conversion of M1 macrophages to anti-
inflammatory M2 cells (100) or by sequential recruitment from distinct precursor 
populations from the blood is currently being debated (101). 
The macrophages can respond to divergent environmental stimulation and 
simultaneously express M1 and M2 phenotypes (102). This ability stems from the 
metabolism of arginine through two enzymatic pathways that negatively regulated 
each other. M1 profile is associated with inducible nitric oxide synthase (NOS2) 
pathway, which leads to arginine conversion in citrulline and nitric oxide (NO) (75). 
M2 profile is associated with arginase 1 (Arg-1) pathway, whereas arginine is 
hydrolyzed to ornithine and urea (Fig. 7) (75).  
The success of the zygote implantation in the uterus during pregnancy, 
requires a transient inflammatory phase initiated by cytokines and prostaglandins 
(75). During the peri-implantation period, the pattern of decidual macrophages 
polarization is shifted to a M1 profile. However, while trophoblasts establish 
connection with the endometrium and invade the uterus stroma, decidual 
macrophages begin transition to a M1/M2 mixed profiles (103). This mixed pattern 
remains in the first trimester and in the beginning of the second trimester of 
pregnancy (104). After the development of the placenta, macrophage activation 
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profile is directed to an M2 profile, which prevents the fetus rejection and allows 
their growth until delivery (75). 
A recent in vivo study in rats, reported that acute infection with T. gondii 
may direct the macrophage activation profile preferably to an M1 profile, producing 
NO and pro-inflammatory cytokines. This can interfere with the maternal-fetal 
immune balance and induce negative consequences in pregnancy and even 
cause abortion (105). 
 
 
10.3.2. F4/80 Marker 
 
The monoclonal antibody F4/80 has been widely used as a marker for 
mouse macrophages (106). This marker is highly expressed in the plasma 
membrane and reveals potential interactions with surrounding cells (107). The 
antigen recognized by the antibody was characterized as a member of the 
epidermal growth factor transmembrane 7 (EGF-TM7) family. F4/80 molecule is 
expressed in a variety of macrophage subsets, including liver Kupffer cells, bone 
marrow macrophages, thymic macrophages, red pulp splenic macrophages, bone 
marrow macrophages of the lymph nodes and microglial cells in the brain (106).  
The F4/80 marker has become widely used for mouse macrophages 
detection. However, not all mouse macrophages express this marker. Thus, in the 
spleen of mice F4/80+ macrophages are present in the red pulp, but not in the 
marginal zone (107). In areas with large amounts of T lymphocytes, such as lymph 
nodes and Peyer's patches, the F4/80 marker is expressed in small amounts, or is 
even non-existent (107). Eosinophils are F4/80+, especially after parasitic infection 
and during tissue remodeling (107). There are also reduced levels of F4/80 found 
in monocytes (106). This protein is absent in neutrophils (107). F4/80+ 
macrophages also exist in mice placenta (108) and mesometrial decidua (109), 
and the numbers may change depending on the gestation day (109).  
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10.4. Dendritic cells 
 
DCs are antigen-presenting cells priming T-cell responses, but decidual 
DCs (dDCs) fail to initiate immunogenic T-cell responses to placental antigens 
contributing, therefore, to the fetomaternal tolerance (79,95,110). One of the 
explanations, is that dDCs, by expressing indoleamine-2,3-dioxygenase (IDO), 
inhibit human T-cell responses (111). In vitro studies showed that T. gondii-
infected human dDCs increased the cytotoxicity of dNK cells, suggesting a 
possible mechanism for abnormal pregnancy outcomes caused by this parasite 
(112). Previous studies in human early pregnancies have shown that IL-12-
producing myeloid dDCs promote a Th2 environment leading to the maintenance 
of pregnancy (79).  
 
 
10.5. Regulatory T cells 
 
During pregnancy, Treg cells are recognized as highly important elements 
for maternal immunological tolerance to the allogeneic fetus (73). Dysfunctional or 
a decreased number of Treg have been found associated with human infertility 
and miscarriage (73,79,111,113). Previous studies have shown that the levels of T 
cell populations rise dramatically in early gestation, reaching a maximum in the 
second trimester, which is concomitant with the extreme trophoblast invasion into 
the maternal decidua, and then decrease to lower levels till post-delivery when the 
allogeneic stimulus has been already removed (79,111,113). During this period, 
fetus-specific Treg cells are being selectively recruited from maternal peripheral 
blood into the decidua, supporting local regulation of fetus-specific responses at 
the FMI (73,79,85,111).  
 
 
       11. L-Arginine metabolism 
 
Arginine is an important amino acid for adult mammals and must be 
provided in the diet in some physiological (such as pregnancy) or pathological 
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conditions, when the need exceeds the capacity of production by the body itself 
(114). 
The enzyme arginase hydrolyzes L-arginine to the products L-ornithine and 
urea. In the mammalian liver, arginase was first discovered by Kossel and Dakin in 
1904 (115). When the existence of a second form of arginase was proven, in 1986 
(116), the liver arginase was designated Arg-1, and the second isoform arginase 2 
(Arg-2). They catalyze the same reaction but differ in cellular expression, 
regulation and localization (117). Thus, Arg-1 is a trimeric cytosolic protein that is 
constitutively expressed only in hepatic tissues or erythrocytes of humans and 
higher primates (118). Arg-2 is also a trimeric mitochondrial protein expressed in 
extrahepatic tissues predominantly in the kidney and prostate (118–120). In 
addition to this, some pathogens possess their own arginase and can use it to 
metabolize L-arginine from the host. Bacteria and parasites explore the effects of 
the depletion of L-arginine as a survival strategy, using its own or host arginase to 
exhaust L-arginine (114). T. gondii is one of the parasites that induces host Arg-1 
protein expression within 1 hour of infection (118). 
Arginase is important in several metabolic pathways because it leads to the 
synthesis of L-ornithine that can be further metabolized to polyamines (putrescine, 
spermidine, spermine) via ornithine decarboxylase (ODC) or to L-proline via 
ornithine aminotransferase (OAT), which is an important component of collagen 
(121). Polyamines are small cationic molecules, that participate in a several 
fundamental cellular functions, such as proliferation and cell membrane transport 
(121). One of the enzymes that competes with arginase for L-arginine is nitric 
oxide synthase (NOS). There are three types of nitric oxide synthases: inducible 
NOS (iNOS or NOS2), neuronal NOS, and endothelial NOS. NOS2 is not 
constitutively expressed but is highly induced by LPS and Type-1 cytokines like 
IFN-γ, tumor necrosis factor alpha (TNF-α), IL-1 and IL-2 (122), and metabolize L-
ornithine to L-citrulline (121). 
In the last years, literature concerning the arginase role in the immune 
system has increased, due to the fact that this enzyme is involved in a critical 
manner in inflammation. Arginase participates in inflammation pathways, triggering 
immune cell dysfunction, and play a role on fibrosis and infectious diseases (114). 
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L-Arginine is transported from the blood into the cells by the cationic amino 
acid transporter (CAT) (123). In myeloid cells (macrophages, granulocytes and 
DCs) the NOS2 and the Arg-1 are competitively regulated by Th1/Th2 cytokines 
and by complex intracellular biochemical pathways, that include the negative 
feedback and competition for the same substrate. Pro-inflammatory signals (such 
as IL-1, TNFα, IFN-γ and IFN-β) and the anti-inflammatory signals (such as IL-10, 
transforming growth factor (TGF)-β, cyclic adenosine monophosphate (AMP), and 
dexamethasone) may contribute to the balance regulation between NOS2 and 
Arg-1. The most important factor for the transcription of Arg-1 is the signal 
transducer and activator of transcription (STAT) 6, but there are other STAT6 
independent pathways. In particular, STAT1 may be necessary for the expression 
of both NOS2 and Arg-1 genes, but the molecular pathway involved has not been 
fully elucidated. Furthermore, Arg-1 and NOS2 directly activate several metabolic 
pathways that are negatively regulated. Low concentration of extracellular L-
arginine, increased Arg-1 expression or reduction of L-arginine absorption capacity 
can decrease intracellular levels of L-arginine and inhibit mRNA translation 
encoding NOS2, thus, reducing this enzyme activity (114). NG-hydroxy-L-arginine 
(NOHA) is an intermediate in the biosynthesis of NO and is a potent competitive 
inhibitor of Arg-1 (123). 
 
 
Figure 7.  Overview of mammalian L-arginine metabolism. DFMO: difluoromethyl ornithine; 
iNOS: inducible nitric oxide synthase; NO: nitric oxide; nor-NOHA: nor-NG-hydroxy-l-arginine; OAT: 
ornithine aminotransferase; ODC: ornithine decarboxylase; PAMPs: pathogen-associated 
molecular patterns; Spd Syn: spermidine synthase; Spm Syn: spermine synthase (118). 
 
The relation between NO and L-arginine are intrinsically connected. L-
ornithine promotes parasite growth, since it is a precursor for a variety of 
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polyamines (putrescine, spermidine and spermine), through the ornithine ODC 
pathway as previously described (121). On the other hand, NO is an effective 
antimicrobial agent that controls pathogens by restricting their access to 
micronutrients (124). Thus, the balance between the expression of NOS2 and Arg-
1 seems to be involved in resistance or susceptibility to infection with T. gondii 
(125). 
Several protozoan parasites develop strategies to circumvent the 
antimicrobial activity mediated by NO. T. gondii inhibits transduction signal 
cascade of IFN-γ induced in murine macrophages, suggesting that NOS2 
expression induced by IFN-γ can also be changed after the parasite infection and 
that T. gondii regulates the production of NO induced by IFN-γ (126). 
 
 
12. The immunobiology response to T. gondii 
 
Epithelial intestinal cells are the first line of defense against T. gondii, since 
this parasite is often transmitted via oral ingestion. However, the parasite can also 
spread and survive in other cells, tissues and organs, such as in DCs and 
macrophages, by taking advantage of their migratory capacity to disseminate 
throughout the body (127). The migration of the immune cells from blood into the 
infection site is highly controlled by diffusible chemotactic factors and cell surface 
adhesion molecules. These migrated acute inflammatory cellular infiltrates consist 
of cells such as neutrophils, DCs, macrophages and NK cells, that play an 
important role in the resistance to T. gondii (128). 
Upon infection, neutrophils are the earliest phagocytic cells recruited to the 
site of infection, phagocyting and killing pathogens by the release of anti-microbial 
compounds and production of reactive oxygen intermediates (ROI) and NO (129). 
Neutrophils have also an immunoregulatory function mediated by the release of 
pro-inflammatory chemokines and cytokines that are able to attract and stimulate 
other immune cells (129). 
After intraperitoneal tachyzoites’ inoculation, there is a local recruitment of 
IL-12-positive neutrophils, whose influx is dependent on the C-X-C chemokine 
receptor (CXCR)2 (130) and the CCR1 (131). During early infection, depletion of 
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neutrophils results on a Th1 shift to a Th2 predominant response, thereby 
increasing susceptibility to the parasite. However, at later stages of infection, the 
removal of neutrophils has no effect, thus highlighting their major role in the initial 
response to T. gondii (129,132). Macrophage inflammatory proteins (MIP)-1α, 
MIP-1β, TNF and monokines acting on CCR5 and CXCR3 expressed by Th1 cells, 
enable neutrophils to support the immune response through Th1 cells (129). MIP-
1α and MIP-1β also attract monocytes, macrophages and DCs to the infection site 
(129). The induction of neutrophils resulting in the elimination of a large number of 
parasites during the initial stages of T. gondii infection is dependent on IL-17 
signaling, a cytokine responsible for neutrophil recruitment and development 
(133). The maturation and activation of DCs in response to infection plays an 
important role in the initiation of innate immunity and in the development of 
adaptive immunity. During infection, DCs migrate into inflammatory sites in 
response to chemokines, such as CCR5 ligands (CCL3, 4 and 5), secreted by 
neutrophils (134). DCs maturation is characterized by the up-regulation of the 
MHC and other stimulatory molecules, inducing the proliferation of naive T cells, 
while DCs activation is associated with production of inflammatory cytokines 
regulating T cell differentiation (135). DCs carrying microbial antigens migrate from 
the infection site to the spleen and accumulate in the T cell areas. In fact, these 
cells are responsible for the most of the antigen-presenting activity and drive the 
polarization of the Th response towards Th1 through the production of IL-12 
(136,137). In addition, since DCs are the major producers of IL-12 in response to a 
T. gondii infection, they became very important for in vivo resistance against 
infection (138). Depletion of DCs has shown to suppress IL-12 production and 
increase mice susceptibility to acute infection (139). The chemokine receptor 
CCR5 has been proven to be involved in DCs mobilization and IL-12 production 
upon T. gondii infection. 
Macrophages, together with DCs, provide the first line of cell-mediated 
defense against pathogens since they are essential to prevent the spread and 
growth of these infectious organisms through the modulation of the resulting 
immunological reactions (140). Macrophage functions include the production of 
cytokines, such as IL-12, presentation of antigens to T cells through the MHC and 
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co-stimulatory molecules leading to microbicidal mechanisms activation, as 
phagocytosis and phagolysosomal degradation, and to adaptive immune 
responses (140,141). 
Macrophages, DCs and neutrophils infected with T. gondii are an important 
source of IL-12 early in infection (142). IL-12 acts first on NK cells and later on T 
cells, and promotes the production of IFN-γ, which, in turn, induces the classical 
activation of macrophages, thus creating a positive feedback. There are two 
signals required for classical activation of macrophages: IFN-γ produced by NK 
and T cells and also, the endogenous TNF-α production by macrophages, in 
response to the activation of pattern recognition receptors (PPRs) by pathogen-
associated molecular patterns (PAMPs) completes activation. These activated 
macrophages in the site of infection phagocyte and destroy the microorganisms by 
releasing lysosomal enzymes, ROI and NO, as well as by inducing nutrient 
deprivation mechanisms, as iron deprivation and tryptophan starvation (140,143). 
Since macrophage overproduction of inflammatory cytokines and NO may 
induce the development of pathology, the activity of these cells needs to be tightly 
regulated. Therefore, signals arising from macrophages or surrounding cells down-
regulate macrophage activation and result in the production of anti-inflammatory 
cytokines, as IL-10 and TGF-β (143). 
 
 
13. Animal Model 
 
Murine models of infection by T. gondii have proved to be useful for the 
study of immune mechanisms that control intracellular parasitic infections (144). 
Nevertheless, the parasite strain used in infection, the mouse strain and infection 
route are critical factors for the development of infection, as can be seen in Table 
2 (144). 
The mice and the rat animal models are often used to study the fetal-
placental development. However, in contrast to humans, the mouse uterine natural 
killer cells (uNK) appear to be very important for arterial remodeling (74). NK cells 
are the predominant cell type in human decidua, rat and mice, whereas 
macrophages are abundant in human decidua but not in mice decidua (80,109). 
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The main difference between the decidualization process in mice, rats and 
humans, is that decidualization starts spontaneously in humans, while in mice or 
rats occurs only in response to a stimulus induced by blastocyst or artificially (74). 
The concern is that pregnancy in mice, rats and humans, although similar in some 
aspects (e.g., in placentation mode and the accumulation of dNK cells), are also 
quite different for other potentially important aspects. Besides the obvious 
differences in the anatomy of the placenta and gestational time (20-21 days versus 
9 months in humans), a critical difference is that the placental trophoblasts do not 
invade deeply arterioles and decidua in the mouse model (80). As in chronically 
infected humans, Balb/c mice do not transmit the disease to their fetuses even if 
re-exposed to infection. The infection of Balb/c mice on the early pregnancy stage 
(until day 7 of gestation), which corresponds to the 1st trimester of human 
pregnancy, results in the loss of embryos due to abortion or resorption. The 
infection in intermediate pregnancy stages results in congenital transmission. 
However, as pregnancy in the mouse is only 21 days, the infection on the later 
pregnancy stages does not seem to be sufficient to occur congenital transmission 
(145). 
 
Table 2.  Strain mice susceptibility to T.gondii acute infection. Adapted from (144). 
 
 INFECTION ROUTE 
STRAIN Oral Intraperitoneal (ip) 
BALB\C Resistant Susceptible 
B6 Susceptible Resistant 
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14. Aims 
 
In the last years, scientific breakthroughs have been made in order to 
understand the immune response to toxoplasmosis, but there is still a lack of 
knowledge about which immune players are responsible for the pathology 
associated with this infection during pregnancy. This immune players are 
potentially associated with the disruption of normal homeostatic immunological 
mechanisms including macrophage activation. 
As it is well known, classical macrophage activation can control parasite 
replication through induction of NOS2, while alternative activation can control 
parasite replication through Arg-1 induction. Therefore, in this work, in a first 
attempt, we hypothesized that Arg-1 and NOS2 expression could be altered during 
pregnancy and T. gondii infection, in order to determine if hypothetical alterations 
could be related to a different macrophage activation profile. 
In this study Balb\c and B6 mice were used. Balb\c and B6 have different 
haplotypes (H-2d and H-2b, respectively), and therefore, antigenic presentation 
and the trigger of the T cell dependent immune responses and consequently 
susceptibility to infection is different, as described (144). Thus, it would be 
expected to find differences in the expression of gene and protein Arg-1 and 
NOS2, and in the polarity of macrophage activation between these two strains of 
mice. 
For this, it was analyzed: I) the effect of infection at the basic parameters of 
reproductive function in pregnancy, by morphometric analysis of decidua and 
placental areas; II) the quantification of parasite burden by Q-PCR; III) the 
evaluation of Arg-1 and NOS2 gene expression by qRT-PCR, 
immunohistochemistry and Western Blotting; and IV) the co-localization of Arg-1 or 
NOS2 and F4/80 by immunofluorescence assay.  
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1. Parasite and in vitro infection 
 
The T. gondii strain used in this study, was the Prugniaud – Yellow 
Fluorescence Protein (YFP), a type II strain (ME49 clone), from Doctor Marcus 
Meissner laboratory (Parasitology department of the Faculty of Medicine, 
Heidelberg University, Germany). Viable tachyzoites were maintained in vitro, 
using Human Foreskin Fibroblasts (HFF) from American Type Culture Collection 
(ATCC), cultivated in Dulbecco’s Modified Eagle Medium (DMEM; Life 
Technologies, Paisley, UK) with L-glutamine, 10% fetal bovine serum (FBS), 100 
U/ml penicillin and 100 µg/ml streptomycin. 
For the maintenance of in vitro parasite cultures, a ratio of 1:10 (HFF cells: 
parasite) was used. After 48h of in vitro infection, parasite suspension was 
obtained, after the disruption of HFF using a needle (26G) and a syringe, 
centrifugation and filtration (0,45 µm), in order to eliminate HFF cell debris. 
Parasites were counted using a Neubauer chamber. 
For in vivo infections, viable tachyzoites were resuspended in saline 
solution to a final concentration of 2,5 x 104/mL.  
 
 
2. Mice and in vivo infection 
 
Balb\c/cByJ (Balb\c) and C57Bl/6 (B6) mice were bred at IBMC facilities 
from breeding pairs purchased from Charles River (Barcelona, Spain). Female and 
male mice with 8-10 weeks were kept in cages in the ratio 2:1, respectively. The 
appearance of the vaginal plug marked the first day of gestation (E1). 
Mice were intraperitoneally infected with 5000 viable tachyzoites obtained 
from T. gondii in vitro infection of HFF. Pregnant Balb\c mice, were infected at day 
7 of gestation (E7) and 5 or 7 days post infection corresponding to day 12 and day 
14 of gestation (E12, E14), mice were sacrificed. B6 pregnant mice were infected 
at E7 of gestation and 5 days pos-infection (E12) mice were sacrificed.  
Four groups of mice were used in this study: pregnant infected, pregnant 
non-infected, non-pregnant infected and non-pregnant non-infected. 
After mice euthanasia, the fetoplacental units (UFs) were collected from 
pregnant animals. The peritoneal exudate cells (PEC) were obtained after washing 
   
 
Determination of Arginase 1 and Nitric Oxide Synthase expression during pregnancy and Toxoplasma 
gondii infection 
 
 
 
29 
the peritoneal cavity with 5 ml of cold Hanks solution. Spleen cell suspensions 
were prepared individually using Potter-Elvehjem tissue homogenizer and 
resuspended in DMEM supplemented with 10% fetal calf serum (FCS, Life 
Technologies). For each mice, three UFs were fixed in 4% paraformaldehyde and 
included in paraffin for histological analysis; and three other UFs were dissected, 
being decidua/placental tissues isolated from the embryo. Decidua/placental 
tissues, PEC and spleen cells were stored at -70ºC in Trizol, ([50-100] mg of tissue 
or [5-10] x 106 cells/ mL of trizol), for later genomic DNA (gDNA), ribonucleic acid 
(RNA) and protein extraction according to manufacturer´s instructions (Invitrogen, 
Carlsbad, CA). 
All procedures involving animals were performed in accordance with the 
recommendations of the European Convention for Protection of Vertebrate 
Animals used for Experimental and other Scientific Purposes (ETS 123) and 
directive 2010/63/EU of the European parliament and of the council of 22 
September 2010 on the protection of the animals used for scientific purposes, and 
Portuguese rules (DL 113/2013). The authorization to perform the experiments 
was issued by competent national board authority, Direcção-Geral de Alimentação 
e Veterinária (0421/000/000/2014). 
  
 
3. Quantitative real-time PCR (q-PCR) 
 
Genomic DNA from the decidua/placenta, PEC and spleen cells from 
infected mice was extracted using Trizol Reagent according to manufacturer’s 
instructions (Invitrogen, Carlsbad, CA). T. gondii genomic DNA was detected using 
primers and a probe designed for the Sag1 gene of T. gondii, giving rise to an 
amplification product of approximately 100 bp. Product amplification was 
performed with 1 µl of template DNA, corresponding to 50 ng (Spleen cells) and 40 
ng (PEC) of DNA in a final volume of 10 µl containing 0.2 µM of each primer (Sag1 
forward: CCAGAGCCTCATCGGTCGTC; Sag1 reverse: GGGTCCTTCCGCAGAC 
AAC), 0.2 µM of probe (6FAM-CTGTyTGCACCGTAGGAGCACCT-BBQ) (all 
designed by Till Molbiol) and KAPA PROBE FAST qPCR Master Mix (Bio-Rad). 
The PCR programme run was as follows: 1) denaturation at 95°C, 3 min; 2) 
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amplification in 40 cycles (denaturation at 95°C, 3 sec; combined 
anneling/extension 60°C, 30 sec). DNA samples corresponding to 102 to 10-2 
ng/µL of parasite DNA, diluted in a solution of 20 µg/µL of host DNA were included 
for creating a standard curve. Quantitative evaluation of fluorescence signals from 
PCR products was performed with Step-One Plus (Applied Biosystems by Life 
Technologies) and analyzed with Step One Software V2.3. 
 
 
4. Histology and Morphometric analysis 
 
After fixation in 4% paraformaldehyde, the UFs were dehydrated, 
embedded in paraffin and sections (4 µm) were obtained using a microtome. 
For morphometric analysis of decidua and placental areas, were used three 
adjacent sections from the center of the UFs, from three UFs, from individual 
animals from each group (n=3). The slides were stained with hematoxylin and 
eosin (H&E) dyes (Sigma-Aldrich), using the standard staining histological 
technique. After staining, slides were mounted in 1,3-diethyl-8-phenylxanthine 
(DPX) mounting medium (VWR Prolabo). 
Decidua and placental areas were determined using the ImageJ image 
analysis software. 
 
 
5. Quantitative Reverse Transcriptase PCR (qRT-PCR) 
 
Total RNA extracted from samples was quantified using Nanodrop ND-1000 
apparatus (Thermo Scientific). Then, 10 µg of total RNA was purified using DNA-
freeTM kit (Ambion). Reverse transcription to complementary (cDNA) was 
performed using 1 µg of total RNA in a final volume of 10 µL, using iScriptTM cDNA 
Synthesis kit (Bio-Rad Laboratories, USA), according to manufacturer’s 
instructions. qRT-PCR was performed for Arg-1 and NOS2 mRNA expression 
levels quantification, using iQTM SYBR Green Supermix (Bio-Rad Laboratories, 
Hercules, CA), in a Step-One PlusTM thermocycler (Applied Biosystems by Life 
Technologies). Hypoxanthine guanine phosphoribosyl transferase (HPRT), was 
used as a house keeping gene. The amplification reaction was performed in a final 
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volume of 10 µL, containing 0.4 µM of each specific primer: Arg1 forward: 
CTCCAAGCCAAAGTCCTTAGAG, Arg1 reverse: AGGAGCTGTCATTAGGGACA 
TC (Tib Molbiol, Berlin, Germany); NOS2 forward: CCAAGCCCTCACCTACTTCC, 
NOS2 reverse: CTCTGAGGGCTGACACAAGG (Tib Molbiol, Berlin, Germany); 
Hprt forward: GCTGGTGAAAAGGACCTCT, Hprt reverse: CACAGGACTAGAACA 
CC (GeneCust, Dudelange, Luxembourg) and 1x Master Mix plus 1 µL of newly-
synthesized cDNA. The PCR program run was as follows: 1) denaturation at 95°C, 
3 min; 2) amplification in 40 cycles (95°C, 15 seg; 60°C, 1 min). The specificity of 
the amplification conditions and primer was assessed by the analysis of the 
melting curve. The fold change in gene expression was calculated using the 
comparative cycle threshold: 2−ΔΔCT (146). 
 
 
6. Western blotting 
 
Protein concentrations were determined by the Bradford assay (147). 
Samples were then subjected to SDS-PAGE (10% running gel; 5% stacking gel) 
and transferred onto a nitrocellulose membrane. Incubation with the primary 
antibodies: goat polyclonal IgG anti-Arg-1 antibody (sc-18351, Santa Cruz 
Biotechnology) diluted to 1:400 in phosphate saline solution (PBS) or rabbit 
polyclonal IgG anti-β-Tubulin antibody (sc-9104, Santa Cruz Biotechnology) 
diluted to 1:500 in PBS, was done at 4ºC overnight. After washing and incubation 
with secondary antibody mouse anti-goat IgG (sc-2354, Santa Cruz 
Biotechnology) diluted to 1:1000 in PBS, or mouse anti-rabbit IgG (sc-2357, Santa 
Cruz Biotechnology) diluted to 1:1000 in PBS, a chemiluminescent substrate (ECL 
Western blotting detection reagent, Super Signal West Pico; Pierce, Rockford, 
USA) was added and film exposed. Bands were quantified by densitometry (BIO-
PROFIL Bio-1D, Vilber Lourmat, France). Data are expressed as volume of the 
western blotting bands, normalized to the volume of β-tubulin, used as a loading 
control. 
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7. Immunohistochemistry 
 
The UFs sections obtained as previously described were used for the 
detection of Arg-1 and NOS2 protein expression.  The sections were incubated at 
100ºC in 10 mM citrate buffer, pH 6.0, for 30 minutes. The primary antibodies used 
were: goat polyclonal IgG anti-Arg-1 (sc-18351, Santa Cruz Biotechnology) diluted 
to 1:100 in PBS; and goat polyclonal IgG anti-NOS2 (sc-650, Santa Cruz 
Biotechnology) diluted to 1:50 in PBS. The immunoreactivity was analyzed using 
an avidin-biotin alkaline phosphatase complex immunohistochemical technique, 
according to manufacturer’s instructions (Vectastain ABC kit, Vector Laboratories, 
CA, USA). Tissue sections were counterstained with Hematoxylin, and mounted 
using Aquatex Mounting Medium (Merck). 
 
 
8. Immunofluorescence 
 
Following dewaxing and hydration, tissues sections were washed with PBS 
and then incubated at 100°C in 10 mM citrate buffer, pH 6.0 for 30 minutes in 
order to proceed to the antigenic recovery. Then, sections were incubated with 
horse normal serum blocking solution diluted to 1:50 in PBS containing 5% bovine 
serum albumin (BSA) for 1 hour. Thereafter the sections were washed with PBS 
and the primary antibody solution diluted to 1:50 in PBS was added and left to 
incubate overnight at 4°C in a humid chamber. The primary antibodies used were 
the rat monoclonal IgG anti-mouse F4/80 (Abcam) and the goat polyclonal IgG 
anti-Arg-1 (sc-18351, Santa Cruz Biotechnology) or the goat polyclonal IgG anti-
NOS2 (sc-650, Santa Cruz Biotechnology). Next day, the sections were washed 
with PBS and incubated with the secondary antibody solution diluted to 1:200 in 
PBS and allowed to incubate 1 hour at room temperature using a dark humid 
chamber. The secondary antibodies used were monkey anti-rat IgG antibody 
labeled with AlexaFluor488 (Molecular Probes) and the bovine anti-goat IgG 
antibody labeled with Texas Red (sc-2786, Santa Cruz Biotechnology). Then, the 
tissue sections were mounted on Fluoroshield with DAPI (4',6-diamidino-2-
phenylindole; Sigma-Aldrich). The images were observed and analyzed in the 
Nikon fluorescence microscope using NIS-Elements imaging system software. 
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9. Statistical analysis 
 
The results are presented as mean ± SD for morphometric analyses and ± 
SE for q-PCR, qRT-PCR and Western Blotting analysis. Statistical differences 
between two groups were determined by the unpaired Student t-test. For multiple 
group comparisons, the one-way ANOVA test with a Tukey’s post-test was 
performed using GraphPad Prism 5.0 software (San Diego, CA, USA). Statistically 
significant differences between infected and non-infected animals were labelled as 
* for P<0.05, ** for P<0.01 and *** for P<0.001, and between the two strains of 
mice were labelled as # for P<0.05, ## for P<0.01 and ### for P<0.001. 
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1. Morphometric analysis of decidua and placenta 
 
During the collection of the UFs, it was macroscopically observed that the 
UFs from infected mice exhibited a reduced size compared to the UFs from non-
infected mice from both mice strains. To determine if these qualitative differences 
were correlated to alterations at the FMI, it was performed morphometric analysis 
of mesometrial decidua and placental areas. H&E stained sections were used from 
infected and non-infected mice from both strains of mice at E12 (Figure 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 8.  Representative histological images of UFs sections stained with H&E. (A1, A2) E12 
non-infected B6; (B) E12 infected B6; (C1, C2) E12 non-infected Balb\c; (D) E12 infected Balb\c. 
PL: placenta; DM: mesometrial decidua; GM: mesometrial gland. 
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To overlap the complete section from non-infected and infected mice, at the 
same magnification, two images were captured from UFs from non-infected mice 
(A1, A2 and C1, C2 for B6 and Balb\c respectively) compared to only one image 
captured for infected mice (B, D for B6 and Balb\c respectively). This histological 
analysis confirmed the previously macroscopical observation. 
Morphometric analysis was performed using three sections from three UF 
of three individual mice from each mice group. Decidua and placental areas were 
delimitated as it is marked in the images (Figure 8). 
In Balb\c mice, no significant differences were observed between infected 
and non-infected mice, probably due to the variability found between the different 
animals analyzed (Figure 9). 
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Figure 9.  Morphometric analysis of decidua and placental areas from E12 pregnant Balb\c 
mice. Each group was comprised of 3 animals. All data are expressed as means ± SD from 3 
sections of 3 individual animals. 
 
However, in B6 mice it was possible to find a significant decrease in the 
decidua and in the placental areas from infected compared to non-infected mice, 
thus confirming earlier macroscopical and microscopical observations (Figure 10). 
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Figure 10. Morphometric analysis of decidua and placental areas from E12 pregnant B6 
mice. Each group of mice was comprised of 3 animals. All data are expressed as means ± SD 
from 3 sections of 3 individual animals.  **P<0.01, *P<0.05 for comparisons of E12 infected versus 
E12 non-infected animals. 
 
These results suggest a delay in the process of decidualisation and 
placentation in B6 mice infected with T.gondii. 
 
 
2. Parasite load quantification 
 
As previously described B6 and Balb\c strains have different susceptibilities 
to T. gondii infection, depending on the route of infection (144). In this work, the 
quantification of parasite load was done using decidua/placental tissues, spleen 
cells and PEC from infected B6 and Balb\c at E12 by amplification of SAG-1 gene 
by q-PCR.  
The quantification of the parasite load in decidua/placental tissues was 
inconclusive for both B6 and Balb\c mice, as in some animals there was no 
amplification of the SAG1 gene, leaving insufficient results for statistical analysis 
(Table 3). This indicates that five days of infection, via ip route, have not been 
sufficient in some animals to allow parasite dissemination from the site of infection 
to the decidua/placental tissues. 
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Table 3.  Parasite load quantification in the Decidua/Placental tissues from E12 infected 
mice. 
Strain ct 
Parasite Quantity 
(ng/µL) 
B6 
Animal 1 Undetermined 0 
Animal 2 Undetermined 0 
Animal 3 38,49 0,003366 
Balb\c 
Animal 1 38,96 0,002472 
Animal 2 Undetermined 0 
Animal 3 40,42 0,000943 
 
NOTE: Parasite load was quantified using a standard curve of known concentrations of parasite 
genomic DNA diluted in host genomic DNA ranging from 102 (100 ng/µL) to 10-2 (0,01 ng/µL). 
 
The parasite burden found in spleen cells and PEC from pregnant Balb\c 
was significantly decreased when compared to non-pregnant Balb\c mice. These 
results indicate that pregnant Balb\c mice are more resistant to infection compared 
to non-pregnant Balb\c mice. Further, the parasite load found in spleen cells and 
PEC from non-pregnant Balb\c mice were significantly increased compared to 
non-pregnant B6 mice confirming, as previously described, that Balb\c strain is 
more susceptible to T. gondii infection than B6 strain, when infected by ip route 
(144). 
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Figure 11.  Parasite load quantification in spleen cells from E12 pregnant or non-pregnant 
B6 or Balb\c mice, either infected with T. gondii. Values are presented as means ± SE from 
three individual mice experiments. **P<0.01 (Differences between pregnant and non-pregnant), 
###P<0.0001 (Differences between strains). 
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Figure 12.  Parasite load quantification in PEC from E12 pregnant or non-pregnant B6 or 
Balb\c mice, either infected with T. gondii. Values are presented as means ± SE from three 
individual mice experiments. **P<0.01 (Differences between pregnant and non-pregnant), ##P<0.01 
(Differences between strains). 
 
No significant differences were found comparing B6 pregnant with non-
pregnant mice, probably due to the lower parasite burden found in this strain and 
the infection time-point chosen to perform this study. However, in Balb\c mice, 
pregnancy causes a decrease in the parasite load of both cell types (Figure 11 
and 12). This could be explained by the immunological status that is changed 
during pregnancy, allowing host survival and the maintenance of pregnancy. By 
contrast, since B6 mice are more resistant to infection compared to Balb\c, it was 
not possible to determine a pregnancy effect on the parasite load. It was also 
observed an increased parasite load in PEC compared to spleen cells from both 
mice strains, due to the infection route chosen in this study. 
 
 
3. Arg-1 and NOS2 gene expression 
 
To evaluate Arg-1 and NOS2 gene expression at the FMI and at systemic 
level, during T. gondii infection, qRT-PCR was performed using decidua/placental 
tissue and spleen cells from different groups of mice: non-infected, infected, E12 
pregnant non-infected and E12 pregnant infected mice. 
The results obtained for decidua/placental tissues indicated a decreased 
Arg-1 and NOS2 gene expression in infected animals, compared to non-infected 
ones (Figure 13A, B). However, a significant decrease was only found for NOS2 
gene expression in infected B6 mice compared to non-infected B6 mice (Figure 
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13B). It was also noticed that Balb\c and B6 strains, have different Arg-1 and 
NOS2 gene expression patterns. Therefore, a increased expression of Arg-1 and a 
decreased expression of NOS2 was found in both non-infected and infected B6, 
compared to Balb\c. Indeed, it was found a significant decrease in Arg-1 gene 
expression comparing non-infected or infected Balb\c with non-infected or infected 
B6 mice, respectively (Figure 13A). It was found a significant increase of NOS2 
gene expression in infected Balb\c compared to infected B6 mice (Figure 13B). 
Moreover, Arg-1 and NOS2 pathways are antagonics, since when we 
observe high levels of Arg-1, NOS2 levels are low and vice versa. These results 
are consistent with the literature, which shows that Arg-1 and NOS2 compete for 
the same substrate (L-arginine), thereby regulating one another (121). 
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Figure 13. Relative expression levels of Arg-1 (A) and NOS2 (B) normalized to HPRT in the 
Decidua/Placenta of E12 pregnant B6 or E12 pregnant Balb\c mice. Values are presented as 
means ± SE from three individual mice. (*) Represent differences in infected animals compared 
with not-infected animals; (#) represent difference between strains. *, # P<0.05. 
 
In the context of pregnancy, the results obtained for spleen cells indicated 
that there were no significant differences for Arg-1 gene expression between the 
A 
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different groups of mice. However, according to the results obtained for 
decidua/placental tissues was found, a significant decrease of NOS2 gene 
expression in E12 pregnant infected B6 mice compared to E12 pregnant non-
infected B6 mice. This may indicate that the same pattern of NOS2 gene 
expression is observed at the FMI and at systemic level. 
However, in spleen cells it was observed that NOS2 gene expression levels 
were increased compared to Arg-1 expression levels in B6 pregnant mice (Figure 
14). This data is not in accordance to what is occurring in the decidua/placenta in 
the same group of animals, that might be explained by the fact of Arg-1 role in 
different organs (UFs versus spleen). Paradoxically, it was observed a significant 
decrease of NOS2 gene expression between E12 pregnant non-infected B6 and 
E12 pregnant non-infected Balb\c (P<0.05). 
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Figure 14.  Relative expression levels of Arg-1 (A) and NOS2 (B) normalized to HPRT in the 
Spleen cells of E12 pregnant B6 or E12 pregnant Balb\c mice. (*) Represent differences in 
infected animals compared with not-infected animals; (#) represent difference between strains. 
Values are present as means ±SE from three individual mice. (ND = Not detected). *, # P<0.05. 
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At systemic level, no significant differences were obtained from Arg-1 and 
NOS2 gene expression between the different groups of non-pregnant animals 
(Figure 15). 
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Figure 15.  Relative expression levels of Arg-1 (A) and NOS2 (B) normalized to HPRT in the 
Spleen cells of B6 and Balb\c mice. Values are present as means ±SE from three individual 
mice. (ND = Not detected). 
 
It was also observed a significative increase of NOS2 expression in 
pregnant non-infected B6 compared to non-pregnant non-infected B6 mice. This 
result suggest that during pregnancy, NOS2 gene expression is increased  in B6 
mice, which is somehow controversial, since NOS2 induces the production of NO, 
known to be harmful for pregnancy. This may also explain the fact that pregnant 
B6 strain is more resistant to T. gondii infection compared to Balb\c strain. 
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Figure16.  Comparing the levels of NOS2 relative expression between E12 pregnant non-
infected and non-infected, B6 or Balb\c mice. Values are present as means ± SE from three 
individual mice. (*) Represent differences between pregnant and non-pregnant animals. *P<0.05. 
 
 
4. Arg-1 protein expression 
 
To evaluate Arg-1 protein expression at the FMI and at systemic level 
during T. gondii infection, western blotting was performed using protein samples 
extracted from decidua/placental tissues, spleen cells and PEC from the four 
groups previously described. 
The results obtained for the decidua/placental tissues indicated a significant 
increase in Arg-1 protein expression of infected B6 compared with non-infected B6 
mice (Figure 17). These results were not in accordance to the results observed for 
the Arg-1 gene expression. This results may suggest, an alternative activation of 
macrophages upon infection with T. gondii at FMI. 
Unfortunately, we have not achieved conclusive results for Balb\c pregnant 
mice due to the decidua/placental tissue samples degradation, thus further 
experiments must be performed. 
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Figure 17.  Densitometry analysis (A) and representative western blotting (B) of Arg-1 in 
decidua/placental tissues obtained from E12 pregnant B6 mice. Data are shown as Arg-1/β-
tubulin ratio and expressed as means ±SE from three individual mice. (*) Represent differences in 
infected animals compared with non-infected animals *P<0.05. 
 
In the pregnancy context, in spleen cells, a tendency for decreasing Arg-1 
protein expression occurs upon T. gondii infection in B6 mice (Figure 18). This 
data constitutes the opposite of what happens in non-pregnant B6 mice, 
suggesting, therefore, that gestation alters the pattern of Arg-1 protein expression 
upon infection with T. gondii in B6 mice (Figure 19). 
It is also possible the observation of differences in the basal levels of this 
protein expression among the two strains of pregnant mice. 
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Figure 18.  Densitometry analysis (A) and representative western blotting (B) of Arg-1 in 
spleen cells obtained from E12 pregnant B6 or Balb\c mice. Data are shown as Arg-1/β-tubulin 
ratio and expressed as means ±SE from three individual mice. (*) Represent differences in infected 
animals compared with non-infected animals; (#) represent difference between strains. *,# P<0.05. 
 
Regarding Balb\c mice, in both E12 pregnant infected and non-pregnant 
infected animals, an increased Arg-1 protein expression is observed, however, no 
significant differences were observed (Figure 18 and 19). Significant differences 
were achieved, between E12 pregnant infected compared to E12 pregnant non-
infected Balb\c mice (Figure 18). These data indicates that pregnancy synergizes 
with infection in the induction of Arg-1 protein expression in Balb\c mice. 
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Figure 19.  Densitometry analysis (A) and representative western blotting (B) of Arg-1 in 
spleen cells obtained from B6 and Balb\c mice. Data are shown as Arg-1/β-tubulin ratio and 
expressed as means ±SE from three individual mice. (*) Represent differences in infected animals 
compared with non-infected animals. * P<0.05. 
 
Pregnancy increased the Arg-1 protein expression in spleen cells of E12 
non-infected B6 mice (Figure 20). These results suggest that pregnancy and 
infection separately increase Arg-1 expression, but the two conditions combined 
seemed to decrease Arg-1 expression in B6 mice (Figure 18, 19 and 20). 
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Figure 20.  Comparing the levels of Arg-1 protein expression between E12 pregnant non-
infected B6 and non-infected B6 mice. Data are shown as Arg-1/β-tubulin ratio and expressed 
as means ±SE from three individual mice. (*) Represent differences in pregnant animals compared 
with non-pregnant animals ** P<0.01. 
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In the context of pregnancy, in PEC, there is an increase and a decrease of 
Arg-1 protein in infected B6 and Balb\c mice, respectively. In this case, it is also 
possible to observe a significant difference between the Arg-1 protein levels of 
E12 pregnant non-infected B6 compared to E12 pregnant non-infected Balb\c 
mice (P<0.001) (Figure 21). These results already suggest a different pattern of 
Arg-1 protein expression in pregnant B6 mice compared to pregnant B6 mice. 
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Figure 21.  Densitometry analysis (A) and representative western blotting (B) of Arg-1 in 
PEC obtained from E12 pregnant B6 or Balb\c mice. Data are shown as Arg-1/β-tubulin ratio 
and expressed as means ±SE from three individual mice. (*) Represent differences in infected 
animals compared with non-infected animals; (#) represent difference between strains. *P<0.05, 
***, ### P<0.001. 
 
In the PEC it’s possible to see an increase in Arg-1 protein expression in 
infected Balb\c mice compared to non-infected Balb\c mice; however, for B6 mice 
there are no differences. A difference between the two strains in the context of 
infection, with higher levels of Arg-1 protein in Balb\c was observed (Figure 22). 
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Figure 22. Densitometry analysis (A) and representative western blotting (B) of Arg-1 in PEC 
obtained from B6 and Balb\c mice. Data are shown as Arg-1/β-tubulin ratio and expressed as 
means ±SE from three individual mice. (*) Represent differences in infected animals compared with 
non-infected animals; (#) represent difference between strains. * P<0.05, ## P<0.01. 
 
 
5. Immunohistochemistry for Arg1 and NOS2 
 
To confirm the results obtained by western blotting, immunohistochemical 
analysis for Arg-1 was performed in order to study protein expression and 
distribution, using UFs sections from the Balb\c E12 or E14, non-infected and 
infected mice, and from B6 E12, non-infected and infected mice. 
In parallel, liver tissue sections, where the Arg-1 is constitutively expressed, 
from non-infected Balb\c mice, were used as internal negative control (no primary 
antibody) and as internal positive control (with primary antibody) (Figure 23A-B) 
(120). 
The figures indicate an increase in specific labeling for Arg-1 in infected 
animals compared to the non-infected animals, for Balb\c E12 and E14 (Figure 
23C-F) and for the B6 E12 (Figure 23G-H).  
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Figure 23.  Representative images of immunohistochemical staining of Arg-1 positive cells 
using UFs sections from E12, E14 Balb\c and E12 B6 mice at the mesometrial decidua. [A] 
Liver of infected Balb\c, negative control; [B] Liver of infected Balb\c, positive control; [C] E14 not-
infected Balb\c; [D] E14 infected Balb\c; [E] E12 not-infected Balb\c; [F] E12 infected Balb\c; [G] 
E12 not-infected B6; [H] E12 infected B6. 
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Immunohistochemical analysis for NOS2 was performed in order to study 
protein expression and distribution, using UFs sections from the Balb\c E12 or 
E14, non-infected and infected mice, and from B6 E12, non-infected and infected 
mice. 
In parallel, liver tissue sections from T. gondii infected Balb\c mice were 
used as internal negative control (no primary antibody) and as internal positive 
control (with primary antibody), since NOS2 is induced in response to infection 
(Figure 24A-B) (121). 
The results for the immunohistochemical analysis of NOS2 showed a 
decrease in specific staining in infected animals compared to the non-infected 
animals for the E12 and E14 Balb\c and for the E12 B6 (Figure 24C-H).  
This decrease of NOS2 expression might be consistent with the literature, 
having in mind that NOS2 and Arg-1 pathways are antagonics. This increased 
Arg-1 expression in infected animals can be related to a decreased NOS2 
expression.  
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Figure 24.  Representative images of immunohistochemical staining of NOS2 positive cells 
using UFs sections from E12, E14 Balb\c and E12 B6 mice at the mesometrial decidua. [A] 
Liver of infected Balb\c, negative control; [B] Liver of infected Balb\c, positive control; [C] E14 not-
infected Balb\c; [D] E14 infected Balb\c; [E] E12 not-infected Balb\c; [F] E12 infected Balb\c; [G] 
E12 not-infected B6; [H] E12 infected B6. 
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6. Immunofluorescence for Arg1 and F4/80 
 
To verify if Arg-1 specific labeling detected by immunohistochemistry is 
linked to alternative macrophage activation, it was performed immunofluorescence 
allowing co-localization of the macrophage marker F4/80 and Arg-1 proteins using 
UF sections from both mice strains. 
It was possible to detect F4/80- cells expressing Arg-1 (F4/80- Arg-1+) in 
infected Balb/c mice, indicating that other cells than macrophages were 
expressing Arg-1, compared with non-infected (Figure 25A-B). In non-infected 
Balb\c it was possible to detect both green and red fluorescence corresponding to 
background, indicating no specific staining for F4/80 or Arg-1 (F4/80- Arg1-) cells 
(Figure 25A). 
In non-infected B6 mice, it was possible to detect F4/80+ cells expressing 
Arg-1 (F4/80+ Arg-1+) indicating that macrophages were expressing Arg-1, 
compared with infected mice (Figure 26A-B). In infected B6 it was possible to 
detect both green and red fluorescence corresponding to background indicating no 
specific staining for F4/80 or Arg-1 (F4/80- Arg1-) cells (Figure 26B). 
This data supports immunohistochemical analysis confirming an increasing 
Arg-1 protein expression in the mesometrial decidua upon infection in Balb/c but 
not in B6 mice. 
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Figure 25. Identification of Arg-1 positive cells in the mesometrial decidua from E12 Balb\c 
mice. (A) E12 non-infected Balb\c; (B) E12 infected Balb\c. Representative UFs sections stained 
with antibodies specific for F4/80 and Arg-1. Arg-1 (red), F4/80+ cells (green). Nuclei were stained 
blue by DAPI. 
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Figure 26. Identification of Arg-1 positive cells in the mesometrial decidua from E12 B6 
mice. (A) E12 non-infected B6; (B) E12 infected B6.  Representative UFs sections stained with 
antibodies specific for F4/80 and Arg-1. Arg-1 (red), F4/80+ cells (green). Nuclei were stained blue 
by DAPI. 
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7. Immunofluorescence for NOS2 and F4/80 
 
To verify if NOS2 specific labeling detected by immunohistochemistry is 
linked to classical macrophage activation, it was performed immunofluorescence 
allowing co-localization of the macrophage marker F4/80 and NOS2 proteins using 
UF sections from both mice strains. 
In relation to NOS2 it was possible to detect F4/80- cells expressing NOS2 
(F4/80- NOS2+) in both non-infected and infected Balb/c mice, indicating that other 
cells than macrophages were expressing NOS2 independent of infection (Figure 
27A-B). It was possible to detect green fluorescence corresponding to background 
indicating no specific staining for F4/80 (Figure 27A-B). In non-infected B6 mice, it 
was possible to detect F4/80- cells expressing NOS2 (F4/80-NOS2+) indicating that 
other cells than macrophages were expressing NOS2 (Figure 28A). In infected B6 
it was possible to detect F4/80+ cells expressing NOS2 (F4/80+NOS2+) indicating 
that macrophages were expressing NOS2 (Figure 28B). This data do not support 
immunohistochemical analysis, therefore further experiments must be performed 
to confirm these results. 
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Figure 27. Identification of NOS2 positive cells in the mesometrial decidua from E12 Balb\c 
mice. (A) E12 non-infected Balb\c; (B) E12 infected Balb\c. Representative UFs sections stained 
with antibodies specific for F4/80 and NOS2. NOS2 (red), F4/80+ cells (green). Nuclei were stained 
blue by DAPI. 
 
 
 
 
 
 
 
DAPI F4/80 NOS2 
A 
B 
   
 
Determination of Arginase 1 and Nitric Oxide Synthase expression during pregnancy and Toxoplasma 
gondii infection 
 
 
 
57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
Figure 28. Identification of NOS2 positive cells in the mesometrial decidua from E12 B6 
mice. (A) E12 non-infected B6; (B) E12 infected B6. Representative UFs sections stained with 
antibodies specific for F4/80 and NOS2. NOS2 (red), F4/80+ cells (green). Nuclei were stained blue 
by DAPI. 
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Chapter IV. DISCUSSION 
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T. gondii is one of the most frequent worldwide parasitic infections, usually 
asymptomatic, when occurs in an immunocompetent host. However, the 
pathophysiology of toxoplasmosis is far more complex when primary infection is 
acquired during pregnancy (52). During primary infection, parasites cross the 
intestinal barrier and invade monocyte cells in contact with the lamina propria, 
which allow them to disseminate through the blood flow, towards virtually all 
organs, including placenta (148).  
In this study, we can observe a delay in the process of decidualization and 
placentation upon infection, in B6 mice, which may have consequences in the 
normal progression of pregnancy, since the decidua/placenta prevents the 
passage of infectious agents towards the foetal compartment. Decidua and 
placenta are key tissues in the mother-to-foetus relationship, not only because of 
their trophic role, but also because they provide a tolerant immune 
microenvironment necessary for gestation progression (149).  
The results indicate, that five days after infection, it was not possible to 
detect in decidual/placental tissues in B6 and Balb\c mice, the T. gondii parasite 
by q-PCR, indicating that probably this period of time was not sufficient to allow 
parasite dissemination from the site of infection (ip route) to the FMI. However, 
analysing the parasite load at systemic level (spleen cells and PEC) we conclude 
that Balb\c mice are more susceptible to T. gondii infection compared to B6 mice, 
which is in agreement with the literature (144). The literature also suggests that 
pregnant mice are more susceptible to infection with T. gondii (150). However, our 
results for Balb\c mice suggest that pregnancy has a protective effect against 
infection, reducing the parasite load of pregnant animals compared to non-
pregnant mice. Since Balb\c mice are more susceptible to infection compared to 
B6 mice during pregnancy, this susceptibility might be camouflaged by some 
mechanisms allowing host survival and pregnancy maintenance. This might not 
occur in B6 strain since they are already more resistant to infection, explaining 
probably the fact that no differences were detected in the parasite load between 
pregnant and non-pregnant B6 mice. 
Macrophages support a variety of essential processes for successful 
pregnancy such as remodelling the uterine connective tissues and blood vessels, 
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regulation of trophoblast implantation, immune-tolerance toward fetal antigens, 
immunomodulation of neighboring leukocytes, and initiation of parturition (151–
155). All of these processes are manifestations of macrophage polarity or state of 
activation, which have been referred to as M1 and M2 (156). M1/M2 activities arise 
from arginine metabolism via two enzymatic pathways, NOS2 and Arg-1 (157). 
Successful pregnancy requires a regulation of macrophage activation state 
throughout pregnancy (158).  
In this study, Arg-1 gene expression was increased in decidua/placental 
tissues from B6 mice, that might indicate a shift toward M2 profile, which is in 
agreement with recent studies indicating that in the second pregnancy stage (7-12 
days), decidua begins to shift towards a pro-M2 environment, which prevents 
rejection of the fetus and allows fetal growth until parturition (153). It is observed 
an increasing NOS2 gene expression in Balb\c mice that might indicate a shift 
towards M1 profile. These results suggest a different gene expression profile 
between these two strains, which can be explained by the need of more NOS2 
production in Balb\c mice, a more susceptible strain of mice, compared to B6, 
since NOS2 is responsible for the production of NO, that can directly kill the 
parasite and prevent congenital infection. There are no significant differences in 
the expression of these genes at systemic level (spleen cells) of non-pregnant 
mice. However, in the context of pregnancy, there is a decrease in NOS2 gene 
expression in spleen cells of infected B6 compared to non-infected B6 mice, 
suggesting that pregnancy in the context of infection leads to an M2 profile in B6 
mice. However, pregnancy alone induces NOS2 expression in B6 mice, which 
may explain the more resistant profile of pregnant B6 mice compared to pregnant 
Balb\c. 
The results for the Arg-1 protein expression suggest an increase of this 
protein upon infection at FMI and spleen cells but not in PEC in non-pregnant B6 
mice. It is also observed that pregnancy itself increases Arg-1 expression. 
Suggesting therefore that pregnancy and infection separately increase Arg-1 
expression, which is consistent with the literature (153). However, the two 
conditions combined (pregnancy and infection) decrease Arg-1 expression. For 
Balb\c mice it is also observed an increase in Arg-1 expression, only in spleen 
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cells of infected pregnant mice and PEC of infected non-pregnant mice. 
The results for Arg-1/NOS2 gene and protein expression showed a 
tendency for M2 profile, however this results were not consistent, especially in 
Balb\c mice. In conclusion, more studies using Balb\c strain will be needed to 
obtain valid results. 
In an attempt to confirm the previous results, immunohistochemical 
analyses were performed at the decidua. The immunohistochemical results are in 
agreement with the previously described hypothesis,  which indicates that T. 
gondii infection induces the expression of Arg-1 and this, in turn, may induce an 
increasing production of polyamines that promote cell division and proliferation of 
the parasites (125,159,160). Furthermore, it is also settled that M2 macrophages 
control the replication of the parasite inducing arginase and depleting arginine 
which is decisive for the microorganisms multiplication (160). The 
imunohistochemical results also suggested a decreasing NOS2 expression that 
leads to a decreasing production of NO, a potent microbicide (125,126,159).  The 
increase of the Arg-1 and decrease of NOS2 expression can be indicative of the 
presence of alternative activated macrophages (102), allowing parasite 
multiplication on one hand, but, on the other hand, prevent the production of NO 
which is hurtful to pregnancy.  
This increase of Arg-1 and decrease of NOS2 upon infection might indicate 
a decreased macrophage activation by the classical pathway (as these are 
characterized by the expression of NOS2) and an increased macrophage 
activation by the alternative pathway (as these are characterized by the 
expression of Arg-1) (75). 
Alternative activation pathway is described, as allowing the maintenance of 
pregnancy preventing abortion, since successful gestation has been thought to be 
accompanied by a bias away from T helper (Th) 1-type cytokines (M1 profile) and 
towards Th2- type cytokines (M2 profile) (161,162). 
Immunofluorescence analysis indicates that other cells, other than 
macrophages express NOS2 and Arg-1 at the FMI. Further experiments are being 
performed in order to clarify the connection between alterations in Arg-1/NOS2 
pathways and macrophage activation profiles at the FMI. 
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Toxoplasmosis is a disease with high incidence in men and some animals. 
In immunosuppressed individuals, the development and dissemination of the 
parasite, occurs leading to clinical manifestations. In healthy individuals, the 
parasite can be in the organism for long periods of time and do not offer any kind 
of danger to the host, unless a breakdown in the normal functioning of the immune 
system occurs. T. gondii may also cause danger if it is acquired during pregnancy, 
passing through the decidua to the fetus resulting in congenital toxoplasmosis and 
can cause abortion or fetal malformations.  
Despite the immune response to toxoplasmosis being well understood 
nowadays, few is known about the immune response to this parasite during 
pregnancy, at FMI and systemic levels. 
As expected, in this study infection with T. gondii affects negatively 
pregnancy, causing a delay in the development of the UF in the B6 strain, but not 
in Balb\c strain. Further experiments using Balb\c mice will be needed to confirm 
these results. Interestingly, the results for the parasite load quantification suggest 
that pregnancy has a protective effect against T. gondii infection, since there is a 
decrease in parasite load of infected Balb\c mice.  
Arg-1 and NOS2 gene showed to be reduced upon T. gondii infection at the 
FMI. However, concerning the evaluation of the Arg-1 protein expression, was 
observed an increase during infection, indicating that although the gene is being 
less expressed, the transcript of the gene is being translated multiple times, and 
this is probably because the protein is being required in greater quantities during 
pregnancy and infection.  
Immunohistochemical analyses confirmed that infection induces an 
increase in Arg-1 protein expression and a decrease in NOS2 protein expression 
at the decidua in B6 and Balb\c mice. These results may indicate the existence of 
M1 and M2 polarized macrophages, proving that both activations occur in 
macrophages in response to infection with T. gondii at the FMI. They also, suggest 
an increase of M2 activated macrophages, indicating an alteration of macrophage 
polarization, in order to maintain pregnancy, but also promoting parasite 
replication and therefore congenital toxoplasmosis.  
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